A Phase III Randomized Study to Assess the Efficacy and Safety of Perifosine Plus Capecitabine Versus Placebo Plus Capecitabine in Patients With Refractory Advanced Colorectal Cancer.
Phase of Trial: Phase III
Latest Information Update: 05 Jun 2015
At a glance
- Drugs Perifosine (Primary) ; Capecitabine
- Indications Colorectal cancer
- Focus Biomarker; Registrational; Therapeutic Use
- Acronyms X-PECT
- 29 Nov 2012 New source identified and integrated (M.D. Anderson Cancer Center; 2010-0257)
- 30 Jun 2012 Trial design and results presented at the 14th World Congress on Gastrointestinal Cancer.
- 05 Jun 2012 Results presented at the 48th Annual Meeting of the American Society of Clinical Oncology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History